Approval · Notice of Compliance 1177 · 2000
FLONASE: Notice of Compliance 1177
Issued February 23, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1177
- Date
- February 23, 2000
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form, new indication: use of flonase nasal drops for the regular treatment of nasal polyps and associated symptoms of nasal obstruction
- Therapeutic class
- Corticosteroid for intranasal use
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLONASE | 02241752 | — |
Medicinal ingredients
- FLUTICASONE PROPIONATE 400 MCG per 0.4ML